Titomic Propriété institutionnelle

Quel est le Propriété institutionnelle de Titomic?

Le Propriété institutionnelle de Titomic Limited est 0.00%

Quelle est la définition de Propriété institutionnelle?



La propriété institutionnelle est le montant des actions disponibles d'une société détenues par des fonds mutuels ou des fonds de pension, des compagnies d'assurance, des sociétés d'investissement, des fonds de dotation ou d'autres grandes entités qui gèrent des fonds pour le compte de tiers.

Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.

Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.

Propriété institutionnelle des entreprises dans Materials secteur sur ASX par rapport à Titomic

Que fait Titomic?

Titomic Limited engages in additive manufacturing activities in Australia. The company focuses on the development and commercialization of the Titomic Kinetic Fusion (TKF) process, an additive manufacturing technology that is used for the application of cold-gas dynamic spraying of titanium or titanium alloy particles onto a scaffold to produce a load-bearing structure. It provides metal powders for additive manufacturing; TKF manufacturing systems, which offers rapid and agile manufacturing, prototyping, custom parts, and pilot runs; TKF bureau manufacturing provides industrial-scale additive manufacturing service. The company also provides research and development services. It serves defense, aerospace, mining, energy, marine, oil and gas, and transport industries. The company was incorporated in 2014 and is headquartered in Notting Hill, Australia.

Entreprises avec propriété institutionnelle similaire à Titomic